Cambridge, Massachusetts-based Biogen Inc. ( BIIB) discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. With a market cap of $23 billion …
Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?
view original post